Progress of relapse after allogeneic hematopoietic stem cell transplantation / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 17-20, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-732678
ABSTRACT
Hematologic neoplasm relapse remains one of the major causes of death after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Relaspe prediction, prophylaxis and treatment after allo-HSCT are the key issues for improving the therapeutic effects and prognosis. This paper chooses some representative reports from 60th American Society of Hematology (ASH) Annual Meeting to discuss the progress of allo-HSCT.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS